ADA and neoplasm: demonstrated that adenosine deaminase (ADA), responsible for deaminating immunosuppressive adenosine to inosine, increases CD4+ effector T cells’ sensitivity to inhibitory signals transmitted by adenosine receptors in HNSCC patients, leading to extracellular adenosine accumulation and affecting the tumor microenvironment (52).